ArticleHaematologica2011

The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

Sylvie Hermouet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.